Russo C, Flomenberg N, Dupont B, Ferrone S
Cell Immunol. 1984 Oct 1;88(1):228-32. doi: 10.1016/0008-8749(84)90068-6.
The anti-HLA-A2 monoclonal antibodies (MoAb) CR11-351 and 4B inhibit the binding of each other to HLA-A2 lymphoid cells and block the cytotoxicity of the anti-HLA-A2 cytotoxic-T-cell clone R32. The blocking does not reflect reactivity of the MoAb CR11-351 and 4B and of the cytotoxic-T-cell clone R32 with the same determinant, since they display differential reactivity with four HLA-A2 variants which carry amino acid substitutions at different positions. These results show for the first time in the human system that Class I HLA variants represent useful reagents to compare the fine specificities of monoclonal antibodies and T-cell clones. Furthermore our data suggest that T-cell recognition depends upon the tertiary structure of the antigen.
抗HLA - A2单克隆抗体(MoAb)CR11 - 351和4B可抑制彼此与HLA - A2淋巴细胞的结合,并阻断抗HLA - A2细胞毒性T细胞克隆R32的细胞毒性。这种阻断并不反映MoAb CR11 - 351和4B以及细胞毒性T细胞克隆R32与相同决定簇的反应性,因为它们对四个在不同位置携带氨基酸取代的HLA - A2变体表现出不同的反应性。这些结果首次在人体系统中表明,I类HLA变体是比较单克隆抗体和T细胞克隆精细特异性的有用试剂。此外,我们的数据表明T细胞识别取决于抗原的三级结构。